| abstract |
Provided herein is a use of pharmaceutical composition for the manufacture of a medicament for use in the treatment and/or prophylaxis of a cancer associated with galectin-1. The pharmaceutical composition is administered to a subject and is mainly composed of ganoderic acid S (GAS) and ganoderic acid T (GAT). Another anti-cancer agent can be administered to the subject before, together with, or after the administration of the pharmaceutical composition, so as to synergistically suppress the growth of the cancer. |